GENCURIX INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,115 KRW | +1.47% |
|
-2.66% | -49.92% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Gencurix Inc. is a Korea-based company mainly engaged in the sale of medical equipments. In addition, the Company is involved in the manufacturing and sale of breast cancer test (BCT) kits, Korean genetic polymorphism diagnostic kits, lung cancer and colorectal cancer diagnostic kits. The BCT kits are used for analyzing the expression level of the cancer-related gene. The products are sold under the name of GenesWell.
Calendar
23/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -49.92% | 32.53M | |
| -6.16% | 12.1B | |
| -3.26% | 8.16B | |
| +6.61% | 5.78B | |
| +31.20% | 5.59B | |
| -9.05% | 4.23B | |
| -56.99% | 2.87B | |
| +11.87% | 2.71B | |
| -5.34% | 2.35B | |
| +25.34% | 2.21B |
- Stock Market
- Equities
- A229000 Stock
- News Gencurix Inc.
- Gencurix to Raise 28 Billion Won From Stock Offering
